Search scope:
排序: Display mode:
Current hepatitis B treatment guidelines and future research directions
Jonathan Skupsky,Ke-Qin Hu
Frontiers of Medicine 2014, Volume 8, Issue 2, Pages 145-157 doi: 10.1007/s11684-014-0335-1
Hepatitis B virus (HBV) infection causes a tremendous clinical burden across the world with more than
Keywords: chronic hepatitis B HBV treatment guidelines APASL guidelines EASL guidelines AASLD guidelines
Frontiers of Medicine 2022, Volume 16, Issue 1, Pages 111-125 doi: 10.1007/s11684-021-0854-5
Keywords: COVID-19 chronic hepatitis B liver injury coagulation dysfunction
Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in China
Rui Yu,Rong Fan,Jinlin Hou
Frontiers of Medicine 2014, Volume 8, Issue 2, Pages 135-144 doi: 10.1007/s11684-014-0331-5
Chronic hepatitis B is a major health problem in China.The universal vaccination program since 1992 has changed the epidemiology of hepatitis B virus infectionThe most prevalent hepatitis B virus strains in China are genotypes B and C, whereas those in westernChronic hepatitis B poses a heavy burden to the society in China.
Keywords: chronic hepatitis B epidemiology prevention treatment
Vaccine therapies for chronic hepatitis B: can we go further?
Yumei Wen, Xuanyi Wang, Bin Wang, Zhenhong Yuan
Frontiers of Medicine 2014, Volume 8, Issue 1, Pages 17-23 doi: 10.1007/s11684-014-0313-7
Chronic hepatitis B is a major health burden worldwide.antiviral treatment, therapeutic vaccination is a promising new strategy for the control of chronic hepatitisB.On the basis of the major specific and non-specific immune dysregulations and defects in chronic hepatitisB patients, this paper presents the peptide and protein-based, DNA-based, cell-based, and antigen-antibody-based
Keywords: chronic hepatitis B therapeutic antigen-antibody complexes DNA vaccine
Lei Li,Yimei Liu,Tiancheng Luo,Jian Zhou,Yingyong Hou,Xizhong Shen,Jiyao Wang
Frontiers of Medicine 2014, Volume 8, Issue 2, Pages 250-253 doi: 10.1007/s11684-014-0333-3
Keywords: acute-on-chronic liver failure submassive necrosis viral hepatitis B esophageal variceal bleeding liver
Correlation between viral load and liver cirrhosis in chronic hepatitis B patients
Lili LIU MM , Jiyao WANG MD , Weimin SHE MM ,
Frontiers of Medicine 2009, Volume 3, Issue 3, Pages 271-276 doi: 10.1007/s11684-009-0054-1
Keywords: hepatitis B chronic viral load liver cirrhosis
MicroRNAs and hepatitis viruses
Gang LI MD , Xiaojia XIONG MM ,
Frontiers of Medicine 2009, Volume 3, Issue 3, Pages 265-270 doi: 10.1007/s11684-009-0055-0
Keywords: microRNA hepatitis B virus hepatitis C virus
Current advances in the elimination of hepatitis B in China by 2030
Shuye Zhang, Fusheng Wang, Zheng Zhang
Frontiers of Medicine 2017, Volume 11, Issue 4, Pages 490-501 doi: 10.1007/s11684-017-0598-4
With its 78 million chronic carriers, hepatitis B virus (HBV) infection is still one of the leadingefficacious in suppressing HBV replication; however, it fails to completely cure patients with chronic hepatitisB and even requires lifelong treatment.Work is still needed to eliminate hepatitis B in China by 2030.
Keywords: HBV CHB biomarker functional cure coinfection
Fengmin Lu, Jie Wang, Xiangmei Chen, Dongping Xu, Ningshao Xia
Frontiers of Medicine 2017, Volume 11, Issue 4, Pages 502-508 doi: 10.1007/s11684-017-0590-z
Although the efficacy of nucleos(t)ide analogue (NA) has been confirmed for treatment of chronic hepatitisB, long-term therapy has been recommended due to the high frequency of off-therapy viral DNA reboundIn this review, the RNA virion-like particles of hepatitis B virus (HBV) are integrated into the lifeIn contrast to hepatitis B surface antigen (HBsAg) that can originate from either the cccDNA or the integratedB, to distinguish the “functional cure” characterized as serum HBsAg loss with or without
Keywords: chronic hepatitis B serum HBV RNA nucleos(t)ide analogs virological response para-functional cure
New perspective on the natural course of chronic HBV infection
Yong-Yuan Zhang,Ke-Qin Hu,Zhongping Duan
Frontiers of Medicine 2014, Volume 8, Issue 2, Pages 129-134 doi: 10.1007/s11684-014-0339-x
Chronic hepatitis B virus (HBV) infection is a significant threat to public health and an enormousmutant becomes predominant in the viral population following elimination of the wild-type virus in duck hepatitisB virus-chronically infected animals.
Keywords: hepatitis B virus chronic HBV infection natural course hepatitis B seroconversion
Jia-Xin XIE, Jian-Hua YIN, Qi ZHANG, Rui PU, Wen-Ying LU, Hong-Wei ZHANG, Guang-Wen CAO, Jun ZHAO, Hong-Yang WANG,
Frontiers of Medicine 2010, Volume 4, Issue 4, Pages 419-429 doi: 10.1007/s11684-010-0160-0
Keywords: hepatitis B virus hepatocellular carcinoma mutation genotype haplotype
Du Yan, Han Xue, Pu Rui, Xie Jiaxin, Zhang Yuwei, Cao Guangwen
Frontiers of Medicine 2014, Volume 8, Issue 2, Pages 217-226 doi: 10.1007/s11684-014-0326-2
Keywords: hepatocellular carcinoma (HCC) interaction miRNA-122-binding site IL-1A rs3783553 hepatitis B virus (
Lei CHEN, Liang HU, Liang LI, Yuan LIU, Qian-Qian TU, Yan-Xin CHANG, He-Xin YAN, Meng-Chao WU, Hong-Yang WANG,
Frontiers of Medicine 2010, Volume 4, Issue 4, Pages 399-411 doi: 10.1007/s11684-010-0170-y
Keywords: hepatocellular carcinoma hepatitis B virus X protein β -catenin cell adhesion E-cadherin transcriptional
Construction and expression of hepatitis B virus vector encoding TC-tagged core protein
Yuanyuan LIN MD, Xiaoming CHENG MS, Yuhu SONG MD, Peiyuan LI MD, Ying CHANG MM, Jinjian YAO MD, Jusheng LIN MD, PhD, Li ZHOU PhD, Leiming XU PhD,
Frontiers of Medicine 2009, Volume 3, Issue 4, Pages 396-402 doi: 10.1007/s11684-009-0056-z
Keywords: hepatitis B virus vector tetracysteine tag core protein
Shasha Zhu, Huimin Zhang, Li Bai
Frontiers of Medicine 2018, Volume 12, Issue 3, Pages 249-261 doi: 10.1007/s11684-018-0622-3
Keywords: natural killer T cells hepatitis B virus and hepatitis C virus infection autoimmune liver diseases alcoholic
Title Author Date Type Operation
Current hepatitis B treatment guidelines and future research directions
Jonathan Skupsky,Ke-Qin Hu
Journal Article
Clinical characteristics and risk factors of COVID-19 patients with chronic hepatitis B: a multi-center
Journal Article
Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in China
Rui Yu,Rong Fan,Jinlin Hou
Journal Article
Vaccine therapies for chronic hepatitis B: can we go further?
Yumei Wen, Xuanyi Wang, Bin Wang, Zhenhong Yuan
Journal Article
Comprehensive treatment of acute-on-chronic liver failure in a patient with hepatitis B: a case report
Lei Li,Yimei Liu,Tiancheng Luo,Jian Zhou,Yingyong Hou,Xizhong Shen,Jiyao Wang
Journal Article
Correlation between viral load and liver cirrhosis in chronic hepatitis B patients
Lili LIU MM , Jiyao WANG MD , Weimin SHE MM ,
Journal Article
Current advances in the elimination of hepatitis B in China by 2030
Shuye Zhang, Fusheng Wang, Zheng Zhang
Journal Article
Potential use of serum HBV RNA in antiviral therapy for chronic hepatitis B in the era of nucleos(t)ide
Fengmin Lu, Jie Wang, Xiangmei Chen, Dongping Xu, Ningshao Xia
Journal Article
New perspective on the natural course of chronic HBV infection
Yong-Yuan Zhang,Ke-Qin Hu,Zhongping Duan
Journal Article
Association of novel mutations and heplotypes in the preS region of hepatitis B virus with hepatocellular
Jia-Xin XIE, Jian-Hua YIN, Qi ZHANG, Rui PU, Wen-Ying LU, Hong-Wei ZHANG, Guang-Wen CAO, Jun ZHAO, Hong-Yang WANG,
Journal Article
Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitisB virus mutations with hepatocellular carcinoma risk
Du Yan, Han Xue, Pu Rui, Xie Jiaxin, Zhang Yuwei, Cao Guangwen
Journal Article
Dysregulation of β-catenin by hepatitis B virus X protein in HBV-infected human hepatocellular carcinomas
Lei CHEN, Liang HU, Liang LI, Yuan LIU, Qian-Qian TU, Yan-Xin CHANG, He-Xin YAN, Meng-Chao WU, Hong-Yang WANG,
Journal Article
Construction and expression of hepatitis B virus vector encoding TC-tagged core protein
Yuanyuan LIN MD, Xiaoming CHENG MS, Yuhu SONG MD, Peiyuan LI MD, Ying CHANG MM, Jinjian YAO MD, Jusheng LIN MD, PhD, Li ZHOU PhD, Leiming XU PhD,
Journal Article